Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

New metric for optimizing Continuous Loop Averaging Deconvolution (CLAD) sequences under the 1/f noise model.

Xian Peng1, Han Yuan2, Wufan Chen1

  • 1School of Biomedical Engineering, Southern Medical University, Guangzhou, Guangdong, PR. China.

Plos One
|April 18, 2017
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Attention guided fair artificial intelligence modeling for skin cancer diagnosis.

NPJ digital medicine·2026
Same author

Multi-modal deep temporal adversarial network based on multi-head self-attention for breast cancer survival prediction.

Computer methods in biomechanics and biomedical engineering·2026
Same author

Unlocking the acquired ultraviolet-resistance and enhanced antioxidant potential of pterostilbene-loaded pharmaceutical-dots.

International journal of pharmaceutics: X·2026
Same author

Artemiannua A, new sesquiterpenoid from the aerial part of <i>artemisia annua</i> with anti-inflammatory activity.

Natural product research·2026
Same author

Recurring transient brain-wide co-activation patterns from EEG spatially resembling time-averaged resting-state networks.

Imaging neuroscience (Cambridge, Mass.)·2026
Same author

3D microscope image acquisition method based on a liquid lens with a translational field of view.

Optics express·2026

A new metric improves noise gain factor (NGF) assessment for continuous loop averaging deconvolution (CLAD) sequences, enhancing auditory evoked potential (AEP) recovery, especially with pink noise. This method optimizes CLAD sequence generation for clinical applications.

Area of Science:

  • Neuroscience
  • Biomedical Engineering
  • Signal Processing

Background:

  • Continuous loop averaging deconvolution (CLAD) is crucial for analyzing auditory evoked potentials (AEPs) in rapid stimulation paradigms.
  • Effective CLAD sequence design is essential to minimize noise interference in electroencephalogram (EEG) data.
  • Existing noise gain factor (NGF) metrics show limitations, particularly with pink (1/f) noise.

Purpose of the Study:

  • To develop and validate a novel metric for evaluating CLAD sequences, specifically addressing limitations with pink noise.
  • To introduce a generalized NGF measurement for more accurate quantification of CLAD sequence performance.
  • To demonstrate the utility of the new metric in optimizing CLAD sequence generation using genetic algorithms.

Main Methods:

Related Experiment Videos

  • Derived a new metric by incorporating a 1/f noise model into a time-continuous sequence framework.
  • Tested the new metric on simulated EEG data and real CLAD EEG recordings to assess middle latency responses.
  • Employed a genetic algorithm to generate and quantify optimized CLAD sequences using the new metric.

Main Results:

  • The new metric demonstrated improved accuracy in measuring actual noise gains across different frequencies compared to the original NGF.
  • The metric showed superior performance in various aspects, particularly in the presence of pink noise.
  • Optimized CLAD sequences generated using the new metric and genetic algorithm exhibited enhanced performance.

Conclusions:

  • The developed metric offers a generalized and more effective approach to quantifying CLAD sequence performance.
  • This advancement facilitates the creation of optimized CLAD sequences for improved AEP analysis.
  • The study supports the enhanced clinical application of the CLAD paradigm with tailored sequences.